Asthma exacerbations during the first trimester of pregnancy and the risk of congenital malformations among asthmatic women

被引:82
作者
Blais, Lucie [1 ]
Forget, Amelie [1 ]
机构
[1] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada
基金
加拿大创新基金会; 加拿大健康研究院;
关键词
asthma; pregnancy; exacerbation; congenital malformations; cohort study; administrative health databases;
D O I
10.1016/j.jaci.2008.02.038
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Uncontrolled maternal asthma during pregnancy has been hypothesized as a cause of congenital malformation, but literature is scare on this topic. Objective: The aim of this study was to investigate whether asthmatic women who had an exacerbation during the first trimester of pregnancy were more at risk of having a baby with a congenital malformation. Methods: From the linkage of 3 Canadian administrative databases, we reconstructed a cohort of 4344 pregnancies of asthmatic women. Asthma exacerbations were assessed during the first trimester of pregnancy and were defined as a filled prescription for oral corticosteroids, an emergency department visit, or a hospitalization for asthma. Congenital malformations were assessed at birth and during the first year of life of the newborn by using diagnoses recorded in the databases. Generalized estimating equation models were used to estimate adjusted odds ratios of congenital malformations in association with asthma exacerbations. Results: In the cohort we identified 398 (9.2%) babies with at least 1 malformation and 261 (6.0%) with a major malformation. The crude prevalences of malformations were 12.8% and 8.9%, respectively, for women who had and those who did not have an exacerbation. The adjusted odds ratio for all malformations was 1.48 (95% CI, 1.04-2.09) when comparing women who had and those who did not have an exacerbation. The corresponding figures were 1.32 (95% CI, 0.86-2.04) for major malformations. Conclusion: Asthma exacerbations during the first trimester of pregnancy were found to significantly increase the risk of a congenital malformation.
引用
收藏
页码:1379 / 1384
页数:6
相关论文
共 48 条
[2]   Asthma medication use in pregnancy and fetal growth [J].
Bakhireva, LN ;
Jones, KL ;
Schatz, M ;
Johnson, D ;
Chambers, CD .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 116 (03) :503-509
[3]   Can guideline-defined asthma control be achieved? The gaining optimal asthma control study [J].
Bateman, ED ;
Boushey, HA ;
Bousquet, J ;
Busse, WW ;
Clark, TJH ;
Pauwels, RA ;
Pedersen, SE .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (08) :836-844
[4]   Management of epilepsy during pregnancy [J].
Battino, Dina ;
Tomson, Torbjorn .
DRUGS, 2007, 67 (18) :2727-2746
[5]   Use of inhaled corticosteroids following discharge from an emergency department for an acute exacerbation of asthma [J].
Blais, L ;
Beauchesne, MF .
THORAX, 2004, 59 (11) :943-947
[6]  
Blais L, 2004, PHARMACOEPIDEM DR S, V13, pS32
[7]   Use of inhaled corticosteroids during the first trimester of pregnancy and the risk of congenital malformations among women with asthma [J].
Blais, Lucie ;
Beauchesne, Marie-France ;
Rey, Evelyne ;
Malo, Jean-Luc ;
Forget, Amelie .
THORAX, 2007, 62 (04) :320-328
[8]  
Boulet LP, 1999, CAN MED ASSOC J, V161, pS1
[9]   Fetal hypoxemia on a molecular level: adaptive changes in the hypothalamic-pituitary-adrenal (HPA) axis and the lungs [J].
Braems, G .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2003, 110 :S63-S69
[10]  
Carmichael SL, 1999, AM J MED GENET, V86, P242, DOI 10.1002/(SICI)1096-8628(19990917)86:3<242::AID-AJMG9>3.0.CO